| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.67 | 0.005 | 0.682 | Anticonvulsant | 0.682 0.005 CID_2555 0.463 0.015 CID_141058406 0.399 0.022 CID_135290 0.441 0.017 CID_129274 | CID_2555 | |
| 0.606 | 0.007 | 0.646 | GABA C receptor rho-3 antagonist | 0.444 0.044 CID_2555 0.609 0.006 CID_141058406 0.646 0.004 CID_135290 0.606 0.007 CID_129274 | CID_135290 | |
| 0.572 | 0.004 | 0.572 | Interleukin 1 antagonist | 0.364 0.008 CID_2555 0.434 0.005 CID_141058406 0.435 0.005 CID_135290 0.431 0.005 CID_129274 | ||
| 0.562 | 0.013 | 0.562 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.484 0.041 CID_2555 0.441 0.068 CID_141058406 0.441 0.068 CID_135290 0.441 0.068 CID_129274 | ||
| 0.517 | 0.007 | 0.528 | Anesthetic general | 0.404 0.016 CID_2555 0.467 0.01 CID_141058406 0.5 0.008 CID_135290 0.528 0.006 CID_129274 | CID_129274 | |
| 0.532 | 0.041 | 0.532 | Analgesic | 0.468 0.059 CID_2555 0.347 0.11 CID_141058406 0.382 0.092 CID_135290 0.415 0.078 CID_129274 | ||
| 0.499 | 0.01 | 0.647 | Peroxidase inhibitor | 0.29 0.039 CID_2555 0.607 0.004 CID_141058406 0.611 0.004 CID_135290 0.647 0.004 CID_129274 | CID_129274 | |
| 0.484 | 0.021 | 0.484 | Interleukin antagonist | 0.402 0.03 CID_2555 0.433 0.026 CID_141058406 0.482 0.021 CID_135290 0.471 0.022 CID_129274 | ||
| 0.49 | 0.029 | 0.525 | 5 Hydroxytryptamine release stimulant | 0.421 0.042 CID_2555 0.36 0.054 CID_141058406 0.447 0.037 CID_135290 0.525 0.023 CID_129274 | CID_129274 | |
| 0.451 | 0.04 | 0.451 | Angiogenesis inhibitor | 0.435 0.043 CID_2555 0.396 0.055 CID_141058406 0.43 0.045 CID_135290 0.378 0.06 CID_129274 | ||
| 0.391 | 0.028 | 0.474 | Superoxide dismutase inhibitor | 0.212 0.105 CID_2555 0.363 0.034 CID_141058406 0.423 0.023 CID_135290 0.474 0.016 CID_129274 | CID_129274 | |
| 0.386 | 0.049 | 0.627 | Aldehyde oxidase inhibitor | 0.231 0.09 CID_2555 0.55 0.026 CID_141058406 0.561 0.024 CID_135290 0.627 0.015 CID_129274 | CID_129274 | |
| 0.345 | 0.01 | 0.345 | Nav1.2 sodium channel blocker | 0.229 0.026 CID_2555 0.273 0.018 CID_141058406 0.265 0.019 CID_135290 0.268 0.019 CID_129274 | ||
| 0.341 | 0.018 | 0.395 | Tyrosine 3 hydroxylase inhibitor | 0.258 0.06 CID_2555 0.351 0.016 CID_141058406 0.395 0.009 CID_135290 0.395 0.009 CID_129274 | CID_129274 | |
| 0.428 | 0.123 | 0.48 | Antiinflammatory | 0.383 0.149 CID_2555 0.454 0.108 CID_141058406 0.434 0.119 CID_135290 0.48 0.096 CID_129274 | CID_129274 | |
| 0.331 | 0.032 | 0.331 | 5 Hydroxytryptamine uptake stimulant | 0.296 0.047 CID_2555 0.297 0.047 CID_141058406 0.297 0.047 CID_135290 0.325 0.034 CID_129274 | ||
| 0.296 | 0.008 | 0.296 | Ferrochelatase inhibitor | 0.145 0.04 CID_2555 0.144 0.04 CID_141058406 0.144 0.04 CID_135290 0.144 0.04 CID_129274 | ||
| 0.303 | 0.028 | 0.336 | Non-steroidal antiinflammatory agent | 0.199 0.072 CID_2555 0.297 0.029 CID_141058406 0.297 0.029 CID_135290 0.336 0.021 CID_129274 | CID_129274 | |
| 0.364 | 0.104 | 0.39 | 5 Hydroxytryptamine release inhibitor | 0.251 0.227 CID_2555 0.363 0.104 CID_141058406 0.354 0.112 CID_135290 0.39 0.085 CID_129274 | CID_129274 | |
| 0.274 | 0.015 | 0.274 | MAP kinase kinase 3 inhibitor | 0.214 0.086 CID_2555 0.213 0.088 CID_141058406 0.213 0.088 CID_135290 0.213 0.088 CID_129274 | ||
| 0.319 | 0.062 | 0.486 | Lipoxygenase inhibitor | 0.232 0.112 CID_2555 0.481 0.021 CID_141058406 0.438 0.029 CID_135290 0.486 0.02 CID_129274 | CID_129274 | |
| 0.358 | 0.111 | 0.5 | Calcium channel L-type activator | 0.467 0.042 CID_141058406 0.5 0.028 CID_135290 0.441 0.056 CID_129274 | CID_135290 | |
| 0.256 | 0.01 | 0.267 | GABA C receptor rho-2 antagonist | 0.164 0.056 CID_2555 0.236 0.015 CID_141058406 0.267 0.009 CID_135290 0.251 0.011 CID_129274 | CID_135290 | |
| 0.284 | 0.045 | 0.284 | Gastrin inhibitor | 0.205 0.141 CID_2555 0.236 0.096 CID_141058406 0.237 0.096 CID_135290 0.217 0.123 CID_129274 | ||
| 0.252 | 0.013 | 0.252 | GABA C receptor agonist | 0.129 0.044 CID_2555 0.184 0.024 CID_141058406 0.184 0.024 CID_135290 0.184 0.024 CID_129274 | ||
| 0.282 | 0.05 | 0.334 | DNA synthesis inhibitor | 0.274 0.054 CID_2555 0.334 0.034 CID_141058406 0.287 0.048 CID_135290 0.285 0.049 CID_129274 | CID_141058406 | |
| 0.311 | 0.081 | 0.311 | Calcium channel activator | 0.233 0.168 CID_2555 0.282 0.111 CID_141058406 0.309 0.083 CID_135290 0.288 0.104 CID_129274 | ||
| 0.244 | 0.019 | 0.244 | 5 Hydroxytryptamine 3E antagonist | 0.202 0.059 CID_2555 0.207 0.052 CID_141058406 0.187 0.088 CID_135290 0.197 0.067 CID_129274 | ||
| 0.231 | 0.019 | 0.231 | Platelet activating factor beta antagonist | 0.119 0.051 CID_141058406 0.177 0.03 CID_135290 0.14 0.041 CID_129274 | ||
| 0.232 | 0.023 | 0.232 | Sodium channel blocker | 0.108 0.1 CID_2555 0.198 0.033 CID_141058406 0.143 0.063 CID_135290 0.162 0.049 CID_129274 | ||
| 0.211 | 0.007 | 0.211 | GABA C receptor rho-1 antagonist | 0.128 0.034 CID_2555 0.179 0.012 CID_141058406 0.203 0.008 CID_135290 0.186 0.01 CID_129274 | ||
| 0.252 | 0.051 | 0.291 | Platelet aggregation inhibitor | 0.291 0.038 CID_2555 0.205 0.078 CID_141058406 0.251 0.051 CID_135290 0.203 0.079 CID_129274 | CID_2555 | |
| 0.262 | 0.062 | 0.262 | 5 Hydroxytryptamine 1E antagonist | 0.259 0.065 CID_141058406 0.233 0.093 CID_135290 0.261 0.063 CID_129274 | ||
| 0.211 | 0.012 | 0.211 | 5 Hydroxytryptamine 3A agonist | 0.112 0.063 CID_2555 0.138 0.042 CID_141058406 0.171 0.025 CID_135290 0.199 0.015 CID_129274 | ||
| 0.208 | 0.011 | 0.218 | Porphobilinogen synthase inhibitor | 0.218 0.01 CID_141058406 0.218 0.01 CID_135290 0.218 0.01 CID_129274 | CID_129274 | |
| 0.207 | 0.012 | 0.207 | GABA C receptor antagonist | 0.144 0.033 CID_2555 0.183 0.017 CID_141058406 0.203 0.012 CID_135290 0.184 0.016 CID_129274 | ||
| 0.217 | 0.023 | 0.217 | Sodium channel (voltage-gated) blocker | 0.111 0.096 CID_2555 0.171 0.042 CID_141058406 0.133 0.069 CID_135290 0.151 0.053 CID_129274 | ||
| 0.197 | 0.006 | 0.219 | NMDA 2B receptor antagonist | 0.06 0.031 CID_2555 0.147 0.009 CID_141058406 0.219 0.005 CID_135290 0.209 0.005 CID_129274 | CID_135290 | |
| 0.206 | 0.02 | 0.206 | Butyrylcholinesterase inhibitor | 0.129 0.043 CID_141058406 0.133 0.041 CID_135290 0.161 0.03 CID_129274 | ||
| 0.193 | 0.007 | 0.327 | Alcohol oxidase inhibitor | 0.072 0.028 CID_2555 0.207 0.006 CID_141058406 0.327 0.004 CID_135290 0.327 0.004 CID_129274 | CID_129274 | |
| 0.272 | 0.088 | 0.295 | Immunostimulant | 0.258 0.093 CID_2555 0.29 0.081 CID_141058406 0.286 0.083 CID_135290 0.295 0.08 CID_129274 | CID_129274 | |
| 0.204 | 0.023 | 0.34 | Cystathionine beta-synthase inhibitor | 0.145 0.043 CID_2555 0.295 0.01 CID_141058406 0.293 0.01 CID_135290 0.34 0.007 CID_129274 | CID_129274 | |
| 0.264 | 0.084 | 0.273 | Insulysin inhibitor | 0.247 0.099 CID_141058406 0.259 0.088 CID_135290 0.273 0.077 CID_129274 | CID_129274 | |
| 0.233 | 0.061 | 0.248 | RNA-directed DNA polymerase inhibitor | 0.198 0.103 CID_2555 0.236 0.059 CID_141058406 0.248 0.05 CID_135290 0.237 0.058 CID_129274 | CID_135290 | |
| 0.252 | 0.079 | 0.292 | DNA damaging | 0.248 0.081 CID_2555 0.278 0.067 CID_141058406 0.292 0.06 CID_135290 0.281 0.065 CID_129274 | CID_135290 | |
| 0.296 | 0.126 | 0.423 | Histamine release inhibitor | 0.208 0.193 CID_2555 0.423 0.064 CID_141058406 0.363 0.094 CID_135290 0.4 0.076 CID_129274 | CID_141058406 | |
| 0.201 | 0.034 | 0.201 | Alpha-N-acetylglucosaminidase inhibitor | 0.143 0.059 CID_2555 0.137 0.063 CID_141058406 0.137 0.063 CID_135290 0.137 0.063 CID_129274 | ||
| 0.184 | 0.018 | 0.184 | Adenylate kinase inhibitor | 0.133 0.034 CID_2555 0.139 0.031 CID_141058406 0.139 0.031 CID_135290 0.139 0.031 CID_129274 | ||
| 0.244 | 0.083 | 0.244 | Interleukin agonist | 0.161 0.157 CID_2555 0.185 0.134 CID_141058406 0.203 0.118 CID_135290 0.223 0.1 CID_129274 | ||
| 0.182 | 0.022 | 0.182 | Sphingosine 1-phosphate receptor 5 antagonist | 0.162 0.043 CID_141058406 0.169 0.034 CID_135290 0.172 0.031 CID_129274 | ||
| 0.173 | 0.016 | 0.307 | Creatine kinase inhibitor | 0.118 0.043 CID_2555 0.307 0.004 CID_141058406 0.306 0.004 CID_135290 0.293 0.004 CID_129274 | CID_141058406 | |
| 0.203 | 0.047 | 0.216 | Succinate dehydrogenase inhibitor | 0.176 0.073 CID_2555 0.2 0.049 CID_141058406 0.2 0.049 CID_135290 0.216 0.038 CID_129274 | CID_129274 | |
| 0.184 | 0.028 | 0.184 | Cathepsin H inhibitor | 0.139 0.055 CID_2555 0.14 0.054 CID_141058406 0.139 0.055 CID_135290 0.139 0.055 CID_129274 | ||
| 0.169 | 0.027 | 0.169 | GABA receptor agonist | 0.123 0.054 CID_141058406 0.125 0.052 CID_135290 0.129 0.049 CID_129274 | ||
| 0.165 | 0.028 | 0.165 | Nav1.4 sodium channel blocker | 0.119 0.053 CID_2555 0.14 0.039 CID_141058406 0.159 0.03 CID_135290 0.159 0.03 CID_129274 | ||
| 0.178 | 0.042 | 0.26 | NADPH oxidase inhibitor | 0.246 0.022 CID_141058406 0.26 0.019 CID_135290 0.26 0.019 CID_129274 | CID_129274 | |
| 0.151 | 0.016 | 0.151 | MAP kinase kinase 1 inhibitor | 0.128 0.028 CID_2555 0.14 0.021 CID_141058406 0.145 0.018 CID_135290 0.137 0.022 CID_129274 | ||
| 0.142 | 0.008 | 0.146 | Purinergic P2X1 antagonist | 0.101 0.016 CID_2555 0.146 0.008 CID_141058406 0.146 0.008 CID_135290 0.146 0.008 CID_129274 | CID_129274 | |
| 0.158 | 0.024 | 0.158 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.127 0.035 CID_2555 0.112 0.044 CID_141058406 0.112 0.044 CID_135290 0.112 0.044 CID_129274 | ||
| 0.169 | 0.036 | 0.169 | Platelet activating factor antagonist | 0.168 0.036 CID_2555 0.106 0.074 CID_141058406 0.143 0.049 CID_135290 0.104 0.075 CID_129274 | ||
| 0.181 | 0.051 | 0.181 | Cyclin-dependent kinase 8 inhibitor | 0.136 0.094 CID_141058406 0.14 0.09 CID_135290 0.139 0.091 CID_129274 | ||
| 0.2 | 0.076 | 0.26 | Neurotrophic factor enhancer | 0.152 0.135 CID_2555 0.235 0.047 CID_141058406 0.234 0.049 CID_135290 0.26 0.033 CID_129274 | CID_129274 | |
| 0.171 | 0.048 | 0.171 | Mannose-6-phosphate isomerase inhibitor | 0.114 0.111 CID_2555 0.165 0.052 CID_141058406 0.159 0.057 CID_135290 0.159 0.057 CID_129274 | ||
| 0.209 | 0.087 | 0.234 | Cyclic AMP phosphodiesterase inhibitor | 0.153 0.148 CID_2555 0.182 0.109 CID_141058406 0.204 0.091 CID_135290 0.234 0.072 CID_129274 | CID_129274 | |
| 0.167 | 0.048 | 0.167 | Histone deacetylase SIRT1 inhibitor | 0.142 0.069 CID_141058406 0.153 0.059 CID_135290 0.156 0.056 CID_129274 | ||
| 0.237 | 0.119 | 0.246 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.22 0.135 CID_141058406 0.246 0.11 CID_135290 0.207 0.149 CID_129274 | CID_135290 | |
| 0.123 | 0.004 | 0.123 | Glutamate (mGluR7) antagonist | 0.103 0.009 CID_2555 0.114 0.005 CID_141058406 0.11 0.006 CID_135290 0.118 0.005 CID_129274 | ||
| 0.135 | 0.019 | 0.135 | Glutamate (mGluR7) agonist | 0.104 0.052 CID_2555 0.09 0.084 CID_141058406 0.09 0.084 CID_135290 0.09 0.084 CID_129274 | ||
| 0.141 | 0.026 | 0.178 | Prolactin inhibitor | 0.103 0.052 CID_2555 0.157 0.019 CID_141058406 0.159 0.019 CID_135290 0.178 0.013 CID_129274 | CID_129274 | |
| 0.127 | 0.012 | 0.131 | Granulocyte macrophage colony stimulating factor agonist | 0.085 0.063 CID_2555 0.131 0.01 CID_141058406 0.13 0.01 CID_135290 0.13 0.011 CID_129274 | CID_141058406 | |
| 0.153 | 0.037 | 0.153 | Sphingosine 1-phosphate receptor 2 antagonist | 0.14 0.056 CID_141058406 0.15 0.041 CID_135290 0.143 0.051 CID_129274 | ||
| 0.121 | 0.006 | 0.121 | Phospholipase D inhibitor | 0.096 0.017 CID_2555 0.09 0.022 CID_141058406 0.088 0.024 CID_135290 0.09 0.022 CID_129274 | ||
| 0.172 | 0.059 | 0.205 | Neurotensin receptor agonist | 0.2 0.035 CID_141058406 0.205 0.032 CID_135290 0.2 0.035 CID_129274 | CID_135290 | |
| 0.303 | 0.191 | 0.385 | Caspase 9 stimulant | 0.38 0.124 CID_2555 0.377 0.125 CID_141058406 0.385 0.12 CID_135290 0.385 0.12 CID_129274 | CID_129274 | |
| 0.2 | 0.088 | 0.22 | Nitric-oxide synthase stimulant | 0.186 0.115 CID_2555 0.204 0.082 CID_141058406 0.199 0.09 CID_135290 0.22 0.06 CID_129274 | CID_129274 | |
| 0.158 | 0.047 | 0.177 | MAP kinase kinase inhibitor | 0.151 0.051 CID_141058406 0.177 0.038 CID_135290 0.171 0.04 CID_129274 | CID_135290 | |
| 0.117 | 0.006 | 0.117 | Aconitate hydratase inhibitor | 0.066 0.021 CID_2555 0.078 0.014 CID_141058406 0.078 0.014 CID_135290 0.078 0.014 CID_129274 | ||
| 0.14 | 0.029 | 0.181 | HIV-1 integrase (Overall Integration) inhibitor | 0.096 0.059 CID_2555 0.181 0.016 CID_141058406 0.135 0.031 CID_135290 0.145 0.027 CID_129274 | CID_141058406 | |
| 0.195 | 0.085 | 0.195 | MAP kinase kinase 2 inhibitor | 0.176 0.099 CID_141058406 0.183 0.094 CID_135290 0.18 0.096 CID_129274 | ||
| 0.15 | 0.041 | 0.15 | Ca2+-transporting ATPase inhibitor | 0.149 0.045 CID_2555 0.144 0.061 CID_141058406 0.144 0.061 CID_135290 0.144 0.061 CID_129274 | ||
| 0.139 | 0.033 | 0.139 | UDP-glucose 4-epimerase inhibitor | 0.13 0.037 CID_2555 0.128 0.038 CID_141058406 0.128 0.038 CID_135290 0.128 0.038 CID_129274 | ||
| 0.123 | 0.017 | 0.172 | Phenylalanine 4-hydroxylase inhibitor | 0.062 0.055 CID_2555 0.144 0.013 CID_141058406 0.172 0.009 CID_135290 0.172 0.009 CID_129274 | CID_129274 | |
| 0.118 | 0.014 | 0.118 | 5 Hydroxytryptamine 3 antagonist | 0.054 0.043 CID_2555 | ||
| 0.144 | 0.04 | 0.144 | Aminopeptidase B inhibitor | 0.113 0.057 CID_141058406 0.128 0.048 CID_135290 0.128 0.048 CID_129274 | ||
| 0.15 | 0.047 | 0.226 | Aldehyde dehydrogenase inhibitor | 0.226 0.022 CID_141058406 0.221 0.023 CID_135290 0.216 0.024 CID_129274 | CID_141058406 | |
| 0.149 | 0.047 | 0.18 | Alkylator | 0.162 0.04 CID_2555 0.172 0.036 CID_141058406 0.18 0.033 CID_135290 0.17 0.037 CID_129274 | CID_135290 | |
| 0.127 | 0.025 | 0.127 | NADH dehydrogenase inhibitor | 0.114 0.032 CID_2555 0.115 0.031 CID_141058406 0.115 0.031 CID_135290 0.124 0.026 CID_129274 | ||
| 0.173 | 0.071 | 0.173 | 3C-like protease (Human coronavirus) inhibitor | 0.142 0.116 CID_141058406 0.138 0.124 CID_129274 | ||
| 0.236 | 0.136 | 0.288 | Cholesterol antagonist | 0.235 0.136 CID_2555 0.222 0.146 CID_141058406 0.258 0.119 CID_135290 0.288 0.099 CID_129274 | CID_129274 | |
| 0.171 | 0.071 | 0.198 | Phospholipase C inhibitor | 0.139 0.131 CID_2555 0.176 0.066 CID_141058406 0.187 0.054 CID_135290 0.198 0.045 CID_129274 | CID_129274 | |
| 0.106 | 0.006 | 0.11 | Cyclin D1 inhibitor | 0.06 0.042 CID_2555 0.105 0.007 CID_141058406 0.11 0.005 CID_135290 0.098 0.009 CID_129274 | CID_135290 | |
| 0.127 | 0.029 | 0.127 | Triose-phosphate isomerase inhibitor | 0.093 0.056 CID_2555 0.104 0.044 CID_141058406 0.104 0.044 CID_135290 0.104 0.044 CID_129274 | ||
| 0.113 | 0.015 | 0.113 | Biliverdin reductase inhibitor | 0.068 0.033 CID_2555 0.064 0.037 CID_141058406 0.064 0.037 CID_135290 0.064 0.037 CID_129274 | ||
| 0.11 | 0.013 | 0.11 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.074 0.023 CID_2555 0.078 0.021 CID_141058406 0.078 0.021 CID_135290 0.078 0.021 CID_129274 | ||
| 0.185 | 0.089 | 0.185 | Psychostimulant | 0.165 0.104 CID_2555 0.168 0.101 CID_141058406 0.182 0.091 CID_135290 0.167 0.102 CID_129274 | ||
| 0.158 | 0.063 | 0.202 | CF transmembrane conductance regulator agonist | 0.202 0.02 CID_141058406 0.17 0.046 CID_135290 0.17 0.046 CID_129274 | CID_141058406 | |
| 0.105 | 0.011 | 0.105 | Protein kinase C beta inhibitor | 0.074 0.04 CID_2555 0.09 0.019 CID_141058406 0.1 0.013 CID_135290 0.104 0.012 CID_129274 | ||
| 0.134 | 0.042 | 0.15 | Protein kinase C gamma inhibitor | 0.123 0.05 CID_141058406 0.142 0.036 CID_135290 0.15 0.031 CID_129274 | CID_129274 | |
| 0.182 | 0.09 | 0.237 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.207 0.067 CID_141058406 0.223 0.056 CID_135290 0.237 0.049 CID_129274 | CID_129274 | |
| 0.134 | 0.044 | 0.156 | TRPA1 agonist | 0.135 0.043 CID_141058406 0.135 0.043 CID_135290 0.156 0.027 CID_129274 | CID_129274 | |
| 0.108 | 0.018 | 0.108 | Carbamoyl phosphate synthetase inhibitor | 0.079 0.029 CID_2555 0.08 0.028 CID_141058406 0.08 0.028 CID_135290 0.08 0.028 CID_129274 | ||
| 0.131 | 0.042 | 0.138 | Transcription factor STAT6 inhibitor | 0.129 0.046 CID_141058406 0.127 0.049 CID_135290 0.138 0.034 CID_129274 | CID_129274 | |
| 0.203 | 0.114 | 0.203 | Neuropeptide Y2 antagonist | 0.184 0.15 CID_135290 0.193 0.132 CID_129274 | ||
| 0.116 | 0.028 | 0.116 | CYP2A6 inhibitor | |||
| 0.1 | 0.014 | 0.1 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.073 0.052 CID_2555 0.081 0.036 CID_141058406 0.072 0.053 CID_135290 0.077 0.044 CID_129274 | ||
| 0.145 | 0.059 | 0.154 | Heat shock protein 70 antagonist | 0.146 0.055 CID_141058406 0.148 0.051 CID_135290 0.154 0.038 CID_129274 | CID_129274 | |
| 0.09 | 0.005 | 0.108 | Ryanodine receptor antagonist | 0.072 0.015 CID_2555 0.094 0.005 CID_141058406 0.096 0.005 CID_135290 0.108 0.004 CID_129274 | CID_129274 | |
| 0.102 | 0.019 | 0.102 | Argininosuccinate synthase inhibitor | 0.056 0.041 CID_2555 0.07 0.03 CID_141058406 0.07 0.03 CID_135290 0.07 0.03 CID_129274 | ||
| 0.116 | 0.033 | 0.116 | Histamine N-methyltransferase inhibitor | 0.076 0.072 CID_141058406 0.095 0.051 CID_135290 0.106 0.04 CID_129274 | ||
| 0.111 | 0.028 | 0.209 | Histidine decarboxylase inhibitor | 0.079 0.043 CID_2555 0.179 0.015 CID_141058406 0.17 0.016 CID_135290 0.209 0.012 CID_129274 | CID_129274 | |
| 0.159 | 0.078 | 0.276 | Heat shock protein 90 alpha antagonist | 0.276 0.019 CID_141058406 0.231 0.034 CID_135290 0.222 0.038 CID_129274 | CID_141058406 | |
| 0.117 | 0.037 | 0.173 | Alcohol dehydrogenase inhibitor | 0.146 0.022 CID_141058406 0.157 0.018 CID_135290 0.173 0.016 CID_129274 | CID_129274 | |
| 0.147 | 0.067 | 0.166 | Adenylate cyclase stimulant | 0.133 0.094 CID_2555 0.147 0.069 CID_141058406 0.155 0.054 CID_135290 0.166 0.04 CID_129274 | CID_129274 | |
| 0.106 | 0.026 | 0.149 | Glutamate decarboxylase inhibitor | 0.069 0.056 CID_2555 0.126 0.019 CID_141058406 0.149 0.013 CID_135290 0.132 0.017 CID_129274 | CID_135290 | |
| 0.122 | 0.043 | 0.172 | DOPA decarboxylase inhibitor | 0.155 0.019 CID_141058406 0.152 0.02 CID_135290 0.172 0.012 CID_129274 | CID_129274 | |
| 0.28 | 0.202 | 0.28 | MAP kinase 1 inhibitor | 0.268 0.214 CID_135290 0.248 0.236 CID_129274 | ||
| 0.116 | 0.04 | 0.116 | Electrolyte absorption antagonist | |||
| 0.102 | 0.027 | 0.133 | D-Ala-D-Ala ligase inhibitor | 0.08 0.069 CID_2555 0.125 0.011 CID_141058406 0.122 0.013 CID_135290 0.133 0.009 CID_129274 | CID_129274 | |
| 0.104 | 0.029 | 0.104 | Glycine receptor antagonist | 0.099 0.033 CID_2555 0.096 0.036 CID_141058406 0.084 0.051 CID_135290 0.082 0.053 CID_129274 | ||
| 0.079 | 0.005 | 0.079 | Vascular adhesion protein 1 inhibitor | 0.047 0.018 CID_2555 0.036 0.032 CID_135290 0.038 0.029 CID_129274 | ||
| 0.096 | 0.023 | 0.096 | Acetylcholine M5 receptor agonist | 0.071 0.043 CID_2555 | ||
| 0.16 | 0.088 | 0.16 | LIM domain kinase 1 inhibitor | 0.128 0.123 CID_141058406 0.129 0.123 CID_135290 0.133 0.117 CID_129274 | ||
| 0.21 | 0.139 | 0.21 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.099 | 0.028 | 0.099 | Aminopeptidase I inhibitor | 0.076 0.046 CID_141058406 0.085 0.038 CID_135290 0.085 0.038 CID_129274 | ||
| 0.077 | 0.007 | 0.09 | Purinergic P2X4 antagonist | 0.085 0.005 CID_141058406 0.09 0.005 CID_135290 0.087 0.005 CID_129274 | CID_135290 | |
| 0.124 | 0.056 | 0.124 | 5 Hydroxytryptamine 2B antagonist | 0.095 0.09 CID_141058406 0.099 0.085 CID_135290 0.093 0.091 CID_129274 | ||
| 0.099 | 0.031 | 0.099 | Glutamate dehydrogenase inhibitor | 0.078 0.047 CID_2555 0.093 0.034 CID_141058406 0.081 0.044 CID_135290 0.081 0.044 CID_129274 | ||
| 0.179 | 0.115 | 0.225 | Aryl hydrocarbon receptor agonist | 0.225 0.09 CID_141058406 0.179 0.114 CID_135290 0.188 0.109 CID_129274 | CID_141058406 | |
| 0.117 | 0.053 | 0.117 | Acetylcholine release stimulant | |||
| 0.114 | 0.05 | 0.203 | Xanthine oxidase inhibitor | 0.185 0.023 CID_141058406 0.193 0.021 CID_135290 0.203 0.019 CID_129274 | CID_129274 | |
| 0.12 | 0.057 | 0.124 | Photosensitizer | 0.115 0.064 CID_141058406 0.124 0.053 CID_135290 0.118 0.06 CID_129274 | CID_135290 | |
| 0.089 | 0.027 | 0.113 | MAP kinase kinase 7 inhibitor | 0.098 0.015 CID_141058406 0.107 0.008 CID_135290 0.113 0.005 CID_129274 | CID_129274 | |
| 0.077 | 0.017 | 0.077 | Calcium channel P-type blocker | 0.061 0.053 CID_141058406 0.061 0.053 CID_135290 0.065 0.038 CID_129274 | ||
| 0.12 | 0.062 | 0.137 | Interleukin 8 antagonist | 0.113 0.071 CID_141058406 0.137 0.044 CID_135290 0.136 0.044 CID_129274 | CID_135290 | |
| 0.089 | 0.031 | 0.089 | Calcium channel L-type blocker | |||
| 0.084 | 0.026 | 0.084 | Cannabinoid CB1 receptor agonist | |||
| 0.08 | 0.024 | 0.08 | Glutamate (mGluR6) antagonist | 0.072 0.036 CID_2555 0.065 0.051 CID_141058406 0.065 0.051 CID_135290 0.065 0.051 CID_129274 | ||
| 0.076 | 0.021 | 0.076 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.139 | 0.083 | 0.144 | Neuropeptide Y1 antagonist | 0.135 0.091 CID_135290 0.144 0.075 CID_129274 | CID_129274 | |
| 0.086 | 0.031 | 0.1 | GABA B receptor agonist | 0.084 0.034 CID_141058406 0.1 0.016 CID_135290 0.097 0.018 CID_129274 | CID_135290 | |
| 0.086 | 0.032 | 0.086 | Glycine receptor agonist | 0.082 0.036 CID_2555 0.076 0.045 CID_141058406 0.076 0.045 CID_135290 0.076 0.045 CID_129274 | ||
| 0.09 | 0.036 | 0.09 | Phosphofructokinase-1 inhibitor | 0.08 0.041 CID_2555 0.076 0.043 CID_141058406 0.076 0.043 CID_135290 0.076 0.043 CID_129274 | ||
| 0.093 | 0.042 | 0.093 | mTOR complex 2 inhibitor | 0.085 0.058 CID_2555 0.081 0.065 CID_129274 | ||
| 0.077 | 0.025 | 0.077 | 5 Hydroxytryptamine 5A antagonist | 0.063 0.04 CID_141058406 0.061 0.044 CID_135290 0.063 0.039 CID_129274 | ||
| 0.079 | 0.028 | 0.079 | 5 Hydroxytryptamine 3 agonist | 0.06 0.049 CID_135290 0.058 0.051 CID_129274 | ||
| 0.065 | 0.016 | 0.065 | Immunoglobulin Fc receptor antagonist | 0.059 0.028 CID_141058406 0.059 0.026 CID_135290 0.061 0.022 CID_129274 | ||
| 0.096 | 0.046 | 0.096 | Bromodomain-containing protein 2 inhibitor | |||
| 0.14 | 0.091 | 0.168 | Hexokinase inhibitor | 0.168 0.059 CID_141058406 0.168 0.06 CID_135290 0.16 0.067 CID_129274 | CID_135290 | |
| 0.157 | 0.109 | 0.277 | Pyruvate kinase inhibitor | 0.277 0.054 CID_141058406 0.252 0.061 CID_135290 0.266 0.057 CID_129274 | CID_141058406 | |
| 0.09 | 0.042 | 0.09 | Catalase inhibitor | 0.065 0.059 CID_135290 0.065 0.059 CID_129274 | ||
| 0.075 | 0.028 | 0.075 | Carbonic anhydrase stimulant | 0.06 0.04 CID_141058406 | ||
| 0.212 | 0.166 | 0.212 | Ca(v)3.3 blocker | |||
| 0.048 | 0.003 | 0.048 | Complement factor D inhibitor | 0.03 0.004 CID_2555 0.026 0.005 CID_141058406 0.033 0.004 CID_135290 0.034 0.004 CID_129274 | ||
| 0.071 | 0.026 | 0.071 | Acyl-CoA dehydrogenase inhibitor | 0.047 0.046 CID_2555 | ||
| 0.107 | 0.064 | 0.107 | Falcipain 3 inhibitor | |||
| 0.141 | 0.099 | 0.166 | Arachidonic acid antagonist | 0.145 0.094 CID_2555 0.152 0.086 CID_141058406 0.142 0.098 CID_135290 0.166 0.07 CID_129274 | CID_129274 | |
| 0.07 | 0.027 | 0.07 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.084 | 0.042 | 0.084 | Histone deacetylase SIRT2 inhibitor | |||
| 0.059 | 0.017 | 0.059 | Poly(ADP-ribose) polymerase inhibitor | |||
| 0.068 | 0.026 | 0.068 | GABA receptor antagonist | 0.052 0.041 CID_141058406 0.054 0.038 CID_135290 0.056 0.036 CID_129274 | ||
| 0.116 | 0.074 | 0.116 | Histone deacetylase class III inhibitor | 0.105 0.084 CID_135290 0.106 0.084 CID_129274 | ||
| 0.118 | 0.076 | 0.118 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.056 | 0.015 | 0.31 | Kinesin antagonist | 0.31 0.003 CID_2555 0.038 0.025 CID_141058406 0.046 0.018 CID_135290 0.059 0.014 CID_129274 | CID_2555 | |
| 0.056 | 0.015 | 0.31 | Kinesin-like protein 1 inhibitor | 0.31 0.003 CID_2555 0.038 0.025 CID_141058406 0.046 0.018 CID_135290 0.059 0.014 CID_129274 | CID_2555 | |
| 0.103 | 0.063 | 0.131 | Carbonic anhydrase XV inhibitor | 0.114 0.052 CID_141058406 0.117 0.049 CID_135290 0.131 0.039 CID_129274 | CID_129274 | |
| 0.068 | 0.028 | 0.068 | 5 Hydroxytryptamine 5 antagonist | 0.055 0.045 CID_141058406 0.053 0.049 CID_135290 0.055 0.045 CID_129274 | ||
| 0.054 | 0.015 | 0.054 | Poly(ADP-ribose) polymerase 1 inhibitor | |||
| 0.241 | 0.202 | 0.247 | MAP kinase kinase 6 inhibitor | 0.247 0.195 CID_141058406 | CID_141058406 | |
| 0.156 | 0.12 | 0.156 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.143 0.137 CID_135290 | ||
| 0.094 | 0.058 | 0.124 | Protein kinase C zeta inhibitor | 0.121 0.032 CID_141058406 0.116 0.035 CID_135290 0.124 0.03 CID_129274 | CID_129274 | |
| 0.081 | 0.045 | 0.089 | GABA aminotransferase inhibitor | 0.073 0.056 CID_141058406 0.089 0.036 CID_135290 0.089 0.036 CID_129274 | CID_129274 | |
| 0.066 | 0.03 | 0.066 | Phosphodiesterase 1A inhibitor | |||
| 0.096 | 0.062 | 0.096 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.051 | 0.017 | 0.051 | Histamine H1 receptor agonist | |||
| 0.062 | 0.029 | 0.062 | GABA A receptor antagonist | 0.048 0.043 CID_135290 0.05 0.041 CID_129274 | ||
| 0.136 | 0.103 | 0.142 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.142 0.087 CID_141058406 0.14 0.093 CID_135290 0.134 0.107 CID_129274 | CID_141058406 | |
| 0.07 | 0.038 | 0.07 | MDM2 inhibitor | |||
| 0.108 | 0.076 | 0.108 | Vascular endothelial growth factor antagonist | |||
| 0.082 | 0.049 | 0.082 | Interferon agonist | 0.071 0.068 CID_141058406 | ||
| 0.051 | 0.019 | 0.051 | Glutamate (mGluR group III) antagonist | 0.04 0.039 CID_141058406 | ||
| 0.052 | 0.02 | 0.052 | Histamine H2 receptor agonist | |||
| 0.091 | 0.059 | 0.091 | Glutamate release inhibitor | 0.089 0.064 CID_2555 0.083 0.079 CID_135290 | ||
| 0.055 | 0.024 | 0.055 | Oleamide hydrolase inhibitor | 0.043 0.034 CID_135290 0.045 0.032 CID_129274 | ||
| 0.071 | 0.04 | 0.071 | Cannabinoid receptor agonist | |||
| 0.055 | 0.024 | 0.055 | Histamine H4 receptor antagonist | |||
| 0.149 | 0.118 | 0.171 | P-glycoprotein inhibitor | 0.162 0.099 CID_141058406 0.153 0.112 CID_135290 0.171 0.088 CID_129274 | CID_129274 | |
| 0.146 | 0.115 | 0.185 | Catenin beta inhibitor | 0.156 0.093 CID_141058406 0.185 0.046 CID_135290 0.175 0.058 CID_129274 | CID_135290 | |
| 0.053 | 0.023 | 0.053 | Cytokine production stimulant | |||
| 0.041 | 0.011 | 0.041 | Adenosine uptake inhibitor | 0.033 0.032 CID_135290 | ||
| 0.128 | 0.098 | 0.137 | MAP3K9 inhibitor | 0.124 0.107 CID_141058406 0.128 0.099 CID_135290 0.137 0.081 CID_129274 | CID_129274 | |
| 0.124 | 0.094 | 0.141 | Cyclooxygenase inhibitor | 0.134 0.084 CID_141058406 0.125 0.093 CID_135290 0.141 0.078 CID_129274 | CID_129274 | |
| 0.068 | 0.038 | 0.068 | Interferon inducer | 0.059 0.055 CID_141058406 | ||
| 0.105 | 0.076 | 0.105 | Calcium channel (voltage-sensitive) blocker | |||
| 0.059 | 0.03 | 0.094 | NMDA 2A receptor antagonist | 0.094 0.015 CID_141058406 0.075 0.022 CID_135290 0.089 0.016 CID_129274 | CID_141058406 | |
| 0.16 | 0.131 | 0.16 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.07 | 0.042 | 0.07 | Exportin-1 inhibitor | |||
| 0.047 | 0.018 | 0.047 | Kainate receptor agonist | 0.04 0.031 CID_2555 0.04 0.033 CID_141058406 0.04 0.033 CID_135290 0.04 0.033 CID_129274 | ||
| 0.07 | 0.042 | 0.07 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.066 | 0.038 | 0.082 | I kappa B kinase 2 inhibitor | 0.082 0.021 CID_141058406 0.058 0.052 CID_135290 0.059 0.048 CID_129274 | CID_141058406 | |
| 0.062 | 0.034 | 0.062 | Cyclin A1 inhibitor | |||
| 0.083 | 0.055 | 0.083 | Caspase 7 inhibitor | |||
| 0.095 | 0.068 | 0.095 | Nitric-oxide synthase inhibitor | |||
| 0.046 | 0.021 | 0.089 | Dopamine D5 agonist | 0.058 0.013 CID_141058406 0.071 0.008 CID_135290 0.089 0.005 CID_129274 | CID_129274 | |
| 0.045 | 0.019 | 0.045 | AMPA 4 receptor antagonist | 0.038 0.031 CID_135290 0.038 0.031 CID_129274 | ||
| 0.098 | 0.073 | 0.098 | Vascular endothelial growth factor 2 antagonist | |||
| 0.087 | 0.063 | 0.087 | Phosphodiesterase I inhibitor | 0.079 0.078 CID_129274 | ||
| 0.084 | 0.059 | 0.097 | Myeloperoxidase inhibitor | 0.097 0.039 CID_141058406 0.095 0.042 CID_135290 0.092 0.046 CID_129274 | CID_141058406 | |
| 0.038 | 0.013 | 0.038 | Cyclin E2 inhibitor | 0.033 0.016 CID_135290 0.026 0.023 CID_129274 | ||
| 0.092 | 0.069 | 0.092 | Sphingomyelinase inhibitor | |||
| 0.049 | 0.027 | 0.049 | Purinergic P2Y antagonist | 0.042 0.034 CID_141058406 0.042 0.034 CID_129274 | ||
| 0.065 | 0.043 | 0.065 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.049 | 0.028 | 0.049 | Farnesyltransferase inhibitor | |||
| 0.054 | 0.033 | 0.063 | Vanilloid 2 antagonist | 0.063 0.02 CID_141058406 0.059 0.024 CID_135290 0.06 0.022 CID_129274 | CID_141058406 | |
| 0.064 | 0.043 | 0.068 | Transcription factor RelA inhibitor | 0.063 0.046 CID_141058406 0.066 0.038 CID_135290 0.068 0.033 CID_129274 | CID_129274 | |
| 0.071 | 0.05 | 0.071 | Benzodiazepine agonist | |||
| 0.041 | 0.02 | 0.041 | Glutamate (mGluR8) agonist | |||
| 0.086 | 0.065 | 0.086 | Pim-3 kinase inhibitor | |||
| 0.126 | 0.105 | 0.126 | Thiol protease inhibitor | |||
| 0.057 | 0.037 | 0.057 | 5 Hydroxytryptamine 7 agonist | 0.055 0.04 CID_135290 0.056 0.039 CID_129274 | ||
| 0.03 | 0.01 | 0.03 | Acid ceramidase inhibitor | |||
| 0.11 | 0.09 | 0.174 | Toll-Like receptor 2 antagonist | 0.156 0.048 CID_141058406 0.146 0.056 CID_135290 0.174 0.037 CID_129274 | CID_129274 | |
| 0.043 | 0.024 | 0.045 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.045 0.022 CID_141058406 0.045 0.022 CID_135290 0.045 0.022 CID_129274 | CID_129274 | |
| 0.048 | 0.029 | 0.048 | Adenylate cyclase 1 inhibitor | |||
| 0.045 | 0.026 | 0.045 | GABA B receptor antagonist | |||
| 0.052 | 0.033 | 0.052 | Antiviral (Hepatitis D) | |||
| 0.029 | 0.01 | 0.029 | Complement factor 1s inhibitor | |||
| 0.054 | 0.036 | 0.054 | Ornithine carbamoyltransferase inhibitor | |||
| 0.068 | 0.051 | 0.07 | Amidase inhibitor | 0.067 0.053 CID_135290 0.07 0.048 CID_129274 | CID_129274 | |
| 0.119 | 0.101 | 0.125 | Cell wall synthesis inhibitor | 0.125 0.092 CID_141058406 0.119 0.1 CID_129274 | CID_141058406 | |
| 0.057 | 0.04 | 0.057 | Pregnane X receptor antagonist | 0.053 0.051 CID_135290 | ||
| 0.041 | 0.024 | 0.041 | Alpha 1d adrenoreceptor agonist | |||
| 0.112 | 0.096 | 0.112 | Calcium channel blocker | |||
| 0.054 | 0.038 | 0.054 | Epithelial sodium channel blocker | 0.053 0.042 CID_135290 | ||
| 0.117 | 0.101 | 0.117 | Nav1.6 sodium channel blocker | |||
| 0.037 | 0.021 | 0.037 | Fumarate hydratase inhibitor | |||
| 0.037 | 0.022 | 0.037 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.04 | 0.026 | 0.04 | Protein kinase (CK1) epsilon inhibitor | |||
| 0.142 | 0.129 | 0.142 | I kappa B kinase epsilon inhibitor | 0.137 0.135 CID_135290 | ||
| 0.043 | 0.03 | 0.043 | Nerve growth factor antagonist | |||
| 0.033 | 0.022 | 0.034 | Protein kinase C beta II inhibitor | 0.033 0.022 CID_135290 0.034 0.019 CID_129274 | CID_129274 | |
| 0.037 | 0.026 | 0.037 | Tryptase inhibitor | |||
| 0.046 | 0.036 | 0.046 | Glucose-6-phosphate isomerase inhibitor | |||
| 0.109 | 0.098 | 0.11 | DNA repair enzyme inhibitor | 0.108 0.103 CID_141058406 0.11 0.095 CID_135290 | CID_135290 | |
| 0.089 | 0.079 | 0.108 | Urease inhibitor | 0.105 0.061 CID_141058406 0.098 0.069 CID_135290 0.108 0.057 CID_129274 | CID_129274 | |
| 0.053 | 0.042 | 0.056 | Sphingosine kinase 2 inhibitor | 0.051 0.046 CID_135290 0.056 0.037 CID_129274 | CID_129274 | |
| 0.089 | 0.079 | 0.11 | Anabolic | 0.097 0.066 CID_141058406 0.096 0.068 CID_135290 0.11 0.049 CID_129274 | CID_129274 | |
| 0.023 | 0.014 | 0.023 | Glutamate (mGluR1a) agonist | |||
| 0.162 | 0.153 | 0.193 | Spasmolytic | 0.171 0.144 CID_141058406 0.183 0.135 CID_135290 0.193 0.125 CID_129274 | CID_129274 | |
| 0.087 | 0.079 | 0.15 | Carbonic anhydrase III inhibitor | 0.121 0.044 CID_141058406 0.15 0.028 CID_135290 0.143 0.031 CID_129274 | CID_135290 | |
| 0.036 | 0.028 | 0.036 | Factor XIIIa inhibitor | |||
| 0.044 | 0.036 | 0.044 | Adenosine deaminase inhibitor | |||
| 0.075 | 0.068 | 0.094 | I kappa B kinase inhibitor | 0.094 0.044 CID_141058406 | CID_141058406 | |
| 0.068 | 0.061 | 0.068 | Adenosine A3 receptor antagonist | |||
| 0.046 | 0.039 | 0.048 | Dopamine beta hydroxylase inhibitor | 0.048 0.034 CID_135290 0.048 0.034 CID_129274 | CID_129274 | |
| 0.066 | 0.059 | 0.066 | Cathepsin G inhibitor | |||
| 0.037 | 0.03 | 0.037 | GABA uptake inhibitor | |||
| 0.028 | 0.021 | 0.028 | Purinergic P2Y15 antagonist | |||
| 0.076 | 0.069 | 0.076 | Inducible nitric-oxide synthase inhibitor | |||
| 0.051 | 0.044 | 0.051 | CC chemokine 2 receptor antagonist | |||
| 0.07 | 0.064 | 0.07 | Vanilloid 4 agonist | |||
| 0.037 | 0.032 | 0.037 | 5 Hydroxytryptamine 2B agonist | |||
| 0.077 | 0.072 | 0.077 | Histamine H2 receptor antagonist | |||
| 0.03 | 0.025 | 0.058 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.033 0.021 CID_141058406 0.051 0.011 CID_135290 0.058 0.009 CID_129274 | CID_129274 | |
| 0.045 | 0.04 | 0.045 | Benzodiazepine antagonist | |||
| 0.034 | 0.031 | 0.034 | Diamine oxidase inhibitor | |||
| 0.02 | 0.018 | 0.02 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.034 | 0.032 | 0.034 | Delayed rectifier potassium channel blocker | |||
| 0.03 | 0.028 | 0.03 | Vanilloid 4 antagonist | |||
| 0.023 | 0.021 | 0.023 | 5 Hydroxytryptamine 4 agonist | |||
| 0.033 | 0.032 | 0.033 | Glutamate (mGluR3) antagonist | |||
| 0.042 | 0.041 | 0.042 | AMPA receptor antagonist | |||
| 0.047 | 0.045 | 0.047 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.032 | 0.031 | 0.032 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.101 | 0.101 | 0.13 | Cyclooxygenase 3 inhibitor | 0.109 0.091 CID_141058406 0.115 0.084 CID_135290 0.13 0.067 CID_129274 | CID_129274 | |
| 0.122 | 0.123 | 0.124 | Pregnane X receptor agonist | 0.124 0.118 CID_2555 | CID_2555 | |
| 0.206 | 0.207 | 0.354 | 15-Lipoxygenase inhibitor | 0.354 0.097 CID_141058406 0.298 0.133 CID_135290 0.338 0.106 CID_129274 | CID_141058406 | |
| 0.06 | 0.063 | 0.11 | NMDA 2 receptor antagonist | 0.096 0.034 CID_141058406 0.11 0.027 CID_135290 0.109 0.028 CID_129274 | CID_135290 | |
| 0.076 | 0.082 | 0.098 | Estrogen-related receptor beta agonist | 0.084 0.056 CID_141058406 0.093 0.035 CID_135290 0.098 0.027 CID_129274 | CID_129274 | |
| 0.032 | 0.043 | 0.039 | Oxytocin agonist | 0.039 0.033 CID_135290 0.039 0.032 CID_129274 | CID_129274 | |
| 0.114 | 0.126 | 0.222 | Heat shock protein 90 antagonist | 0.222 0.029 CID_141058406 0.182 0.048 CID_135290 0.173 0.054 CID_129274 | CID_141058406 | |
| 0.114 | 0.126 | 0.138 | Phospholipase A2 inhibitor | 0.12 0.117 CID_141058406 0.133 0.095 CID_135290 0.138 0.089 CID_129274 | CID_129274 | |
| 0.184 | 0.197 | 0.2 | Vasodilator, coronary | 0.2 0.182 CID_2555 | CID_2555 | |
| 0.048 | 0.061 | 0.053 | Sphingosine 1-phosphate receptor 3 antagonist | 0.053 0.05 CID_135290 | CID_135290 | |
| 0.041 | 0.055 | 0.048 | Carbonic anhydrase VB inhibitor | 0.048 0.046 CID_129274 | CID_129274 | |
| 0.064 | 0.079 | 0.09 | Keratolytic | 0.081 0.047 CID_141058406 0.082 0.046 CID_135290 0.09 0.038 CID_129274 | CID_129274 | |
| 0.046 | 0.062 | 0.081 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.069 0.031 CID_141058406 0.066 0.034 CID_135290 0.081 0.024 CID_129274 | CID_129274 | |
| 0.084 | 0.1 | 0.128 | Beta glucuronidase inhibitor | 0.128 0.038 CID_141058406 0.121 0.045 CID_135290 0.123 0.043 CID_129274 | CID_141058406 | |
| 0.062 | 0.08 | 0.081 | Somatostatin 1 agonist | 0.081 0.05 CID_135290 0.081 0.05 CID_129274 | CID_129274 | |
| 0.023 | 0.043 | 0.029 | Estrogen-related receptor gamma antagonist | 0.029 0.019 CID_135290 0.029 0.019 CID_129274 | CID_129274 | |
| 0.106 | 0.127 | 0.118 | Vanilloid 1 agonist | 0.118 0.093 CID_141058406 0.112 0.108 CID_135290 0.117 0.095 CID_129274 | CID_141058406 | |
| 0.07 | 0.092 | 0.132 | MAO A inhibitor | 0.132 0.047 CID_141058406 0.109 0.058 CID_135290 0.122 0.051 CID_129274 | CID_141058406 | |
| 0.073 | 0.095 | 0.084 | CC chemokine 5 receptor agonist | 0.084 0.051 CID_129274 | CID_129274 | |
| 0.011 | 0.035 | 0.016 | Nicotinic acid receptor 1 antagonist | 0.016 0.015 CID_129274 | CID_129274 | |
| 0.063 | 0.087 | 0.092 | Carbonic anhydrase VI inhibitor | 0.078 0.059 CID_141058406 0.079 0.058 CID_135290 0.092 0.045 CID_129274 | CID_129274 | |
| 0.039 | 0.063 | 0.05 | Topoisomerase II beta inhibitor | 0.049 0.035 CID_141058406 0.05 0.033 CID_129274 | CID_129274 | |
| 0.084 | 0.109 | 0.146 | MAO inhibitor | 0.146 0.062 CID_141058406 0.121 0.074 CID_135290 0.139 0.066 CID_129274 | CID_141058406 | |
| 0.065 | 0.09 | 0.114 | MAO B inhibitor | 0.114 0.053 CID_141058406 0.092 0.064 CID_135290 0.11 0.055 CID_129274 | CID_141058406 | |
| 0.03 | 0.056 | 0.061 | NMDA receptor subunit 3B antagonist | 0.061 0.019 CID_141058406 0.051 0.024 CID_135290 0.05 0.025 CID_129274 | CID_141058406 | |
| 0.043 | 0.069 | 0.064 | Fatty acid synthase inhibitor | 0.064 0.03 CID_141058406 0.052 0.048 CID_129274 | CID_141058406 | |
| 0.018 | 0.044 | 0.026 | CC chemokine 8 receptor antagonist | 0.026 0.011 CID_2555 | CID_2555 | |
| 0.041 | 0.067 | 0.048 | CD45 antagonist | 0.048 0.039 CID_129274 | CID_129274 | |
| 0.055 | 0.083 | 0.113 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.113 0.032 CID_141058406 0.107 0.034 CID_135290 0.097 0.039 CID_129274 | CID_141058406 | |
| 0.098 | 0.126 | 0.133 | Protein kinase stimulant | 0.133 0.081 CID_135290 0.131 0.083 CID_129274 | CID_135290 | |
| 0.047 | 0.075 | 0.088 | Heat shock protein 90 beta antagonist | 0.088 0.016 CID_141058406 0.071 0.027 CID_135290 0.069 0.029 CID_129274 | CID_141058406 | |
| 0.026 | 0.055 | 0.036 | Antibiotic Aminoglycoside-like | 0.036 0.026 CID_2555 | CID_2555 | |
| 0.186 | 0.215 | 0.249 | Interleukin 2 agonist | 0.212 0.169 CID_141058406 0.237 0.134 CID_135290 0.249 0.119 CID_129274 | CID_129274 | |
| 0.08 | 0.115 | 0.094 | Mucolytic | 0.094 0.086 CID_129274 | CID_129274 | |
| 0.124 | 0.159 | 0.14 | ATPase inhibitor | 0.14 0.119 CID_2555 | CID_2555 | |
| 0.061 | 0.098 | 0.106 | NMDA receptor antagonist | 0.106 0.043 CID_141058406 0.094 0.051 CID_135290 0.097 0.049 CID_129274 | CID_141058406 | |
| 0.04 | 0.079 | 0.054 | Androgen agonist | 0.054 0.05 CID_129274 | CID_129274 | |
| 0.075 | 0.115 | 0.098 | Adenylate cyclase inhibitor | 0.098 0.086 CID_129274 | CID_129274 | |
| 0.113 | 0.154 | 0.14 | Interferon gamma antagonist | 0.14 0.092 CID_2555 0.14 0.092 CID_135290 0.14 0.092 CID_129274 | CID_129274 | |
| 0.126 | 0.167 | 0.151 | Insulin sensitizer | 0.147 0.137 CID_135290 0.151 0.132 CID_129274 | CID_129274 | |
| 0.022 | 0.063 | 0.069 | Estradiol 17 beta-dehydrogenase inhibitor | 0.046 0.027 CID_141058406 0.05 0.025 CID_135290 0.069 0.016 CID_129274 | CID_129274 | |
| 0.074 | 0.116 | 0.093 | Bile acid receptor antagonist | 0.088 0.079 CID_135290 0.093 0.065 CID_129274 | CID_129274 | |
| 0.147 | 0.19 | 0.168 | MAP-kinase-activated kinase 5 inhibitor | 0.168 0.151 CID_135290 0.164 0.158 CID_129274 | CID_135290 | |
| 0.031 | 0.074 | 0.076 | Xanthine dehydrogenase inhibitor | 0.057 0.04 CID_141058406 0.076 0.027 CID_135290 0.071 0.031 CID_129274 | CID_135290 | |
| 0.036 | 0.08 | 0.068 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.052 0.039 CID_141058406 0.054 0.036 CID_135290 0.068 0.023 CID_129274 | CID_129274 | |
| 0.078 | 0.124 | 0.164 | Amylase inhibitor | 0.121 0.08 CID_141058406 0.136 0.071 CID_135290 0.164 0.058 CID_129274 | CID_129274 | |
| 0.035 | 0.083 | 0.048 | Protein kinase C eta inhibitor | 0.048 0.047 CID_129274 | CID_129274 | |
| 0.17 | 0.22 | 0.215 | Antithrombotic | 0.215 0.159 CID_2555 | CID_2555 | |
| 0.019 | 0.069 | 0.041 | NMDA receptor subunit 3A antagonist | 0.041 0.025 CID_141058406 | CID_141058406 | |
| 0.126 | 0.175 | 0.152 | Death-associated protein kinase 2 inhibitor | 0.141 0.129 CID_135290 0.152 0.102 CID_129274 | CID_129274 | |
| 0.114 | 0.163 | 0.236 | Interleukin 6 antagonist | 0.236 0.026 CID_2555 0.143 0.101 CID_141058406 0.146 0.095 CID_135290 0.142 0.102 CID_129274 | CID_2555 | |
| 0.016 | 0.067 | 0.024 | Thyroid hormone agonist | 0.024 0.023 CID_129274 | CID_129274 | |
| 0.079 | 0.132 | 0.11 | Microtubule formation inhibitor | 0.11 0.074 CID_2555 | CID_2555 | |
| 0.02 | 0.074 | 0.119 | Somatostatin 5 agonist | 0.119 0.004 CID_2555 | CID_2555 | |
| 0.073 | 0.129 | 0.097 | AMP-activated protein kinase stimulant | 0.097 0.074 CID_141058406 | CID_141058406 | |
| 0.052 | 0.111 | 0.114 | Macrophage migration inhibitory factor inhibitor | 0.114 0.028 CID_135290 0.113 0.029 CID_129274 | CID_135290 | |
| 0.048 | 0.106 | 0.062 | Beta 3 adrenoreceptor antagonist | 0.062 0.051 CID_129274 | CID_129274 | |
| 0.022 | 0.082 | 0.065 | Growth hormone release inhibitor | 0.065 0.014 CID_2555 | CID_2555 | |
| 0.047 | 0.107 | 0.087 | Analgesic, opioid | 0.076 0.052 CID_135290 0.087 0.04 CID_129274 | CID_129274 | |
| 0.107 | 0.167 | 0.152 | Melanin inhibitor | 0.136 0.103 CID_141058406 0.138 0.1 CID_135290 0.152 0.079 CID_129274 | CID_129274 | |
| 0.114 | 0.176 | 0.157 | MAP kinase kinase 4 inhibitor | 0.146 0.071 CID_141058406 0.143 0.077 CID_135290 0.157 0.049 CID_129274 | CID_129274 | |
| 0.077 | 0.139 | 0.099 | Caspase 3 inhibitor | 0.099 0.094 CID_141058406 | CID_141058406 | |
| 0.1 | 0.165 | 0.126 | Growth hormone agonist | 0.126 0.111 CID_135290 0.126 0.111 CID_129274 | CID_129274 | |
| 0.118 | 0.184 | 0.182 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.182 0.112 CID_141058406 | CID_141058406 | |
| 0.052 | 0.118 | 0.094 | Potassium channel (Ca-activated) activator | 0.094 0.06 CID_141058406 | CID_141058406 | |
| 0.04 | 0.11 | 0.065 | Carbonic anhydrase XIII inhibitor | 0.065 0.063 CID_129274 | CID_129274 | |
| 0.033 | 0.108 | 0.043 | Beta adrenoreceptor agonist | 0.043 0.039 CID_135290 | CID_135290 | |
| 0.105 | 0.181 | 0.154 | DNA methylase inhibitor | 0.154 0.114 CID_135290 0.141 0.126 CID_129274 | CID_135290 | |
| 0.042 | 0.124 | 0.071 | Histone deacetylase SIRT1 stimulant | 0.071 0.053 CID_135290 0.067 0.058 CID_129274 | CID_135290 | |
| 0.042 | 0.124 | 0.071 | Histone deacetylase stimulant | 0.071 0.053 CID_135290 0.067 0.058 CID_129274 | CID_135290 | |
| 0.058 | 0.141 | 0.095 | Uric acid excretion stimulant | 0.086 0.071 CID_141058406 0.093 0.06 CID_135290 0.095 0.058 CID_129274 | CID_129274 | |
| 0.047 | 0.132 | 0.06 | Beta 2 adrenoreceptor agonist | 0.06 0.052 CID_135290 | CID_135290 | |
| 0.01 | 0.097 | 0.015 | Antibiotic Tetracycline-like | 0.015 0.012 CID_141058406 | CID_141058406 | |
| 0.076 | 0.165 | 0.113 | Alkaline phosphatase inhibitor | 0.113 0.096 CID_141058406 | CID_141058406 | |
| 0.097 | 0.187 | 0.141 | DNA methyltransferase I inhibitor | 0.141 0.114 CID_135290 0.134 0.124 CID_129274 | CID_135290 | |
| 0.045 | 0.142 | 0.12 | Monophenol monooxygenase inhibitor | 0.117 0.063 CID_141058406 0.103 0.073 CID_135290 0.12 0.061 CID_129274 | CID_129274 | |
| 0.044 | 0.146 | 0.08 | Adrenaline agonist | 0.08 0.058 CID_135290 0.075 0.064 CID_129274 | CID_135290 | |
| 0.038 | 0.141 | 0.071 | Platelet growth factor antagonist | 0.071 0.068 CID_135290 | CID_135290 | |
| 0.048 | 0.153 | 0.14 | 5-Lipoxygenase inhibitor | 0.14 0.041 CID_141058406 0.111 0.055 CID_135290 0.137 0.043 CID_129274 | CID_141058406 | |
| 0.087 | 0.202 | 0.17 | NOS3 expression enhancer | 0.141 0.082 CID_141058406 0.141 0.082 CID_135290 0.17 0.056 CID_129274 | CID_129274 | |
| 0.102 | 0.223 | 0.139 | Lipocortins synthesis antagonist | 0.139 0.123 CID_129274 | CID_129274 | |
| 0.131 | 0.254 | 0.207 | Hypoxia-inducible factor 1 alpha inhibitor | 0.184 0.173 CID_141058406 0.187 0.168 CID_135290 0.207 0.144 CID_129274 | CID_129274 | |
| 0.132 | 0.255 | 0.192 | Peptidyltransferase inhibitor | 0.192 0.11 CID_141058406 0.182 0.126 CID_135290 0.182 0.126 CID_129274 | CID_141058406 | |
| 0.048 | 0.184 | 0.076 | Estrogen receptor alpha antagonist | 0.07 0.068 CID_141058406 0.075 0.057 CID_135290 0.076 0.055 CID_129274 | CID_129274 | |
| 0.154 | 0.292 | 0.263 | Antibacterial | 0.263 0.165 CID_141058406 | CID_141058406 | |
| 0.133 | 0.285 | 0.229 | Alpha-glucosidase inhibitor | 0.229 0.2 CID_129274 | CID_129274 | |
| 0.051 | 0.213 | 0.101 | Cyclooxygenase 1 inhibitor | 0.101 0.099 CID_129274 | CID_129274 | |
| 0.079 | 0.247 | 0.152 | Hepatoprotectant | 0.146 0.114 CID_141058406 0.152 0.108 CID_129274 | CID_129274 | |
| 0.111 | 0.281 | 0.218 | 12-Lipoxygenase inhibitor | 0.218 0.132 CID_141058406 0.201 0.15 CID_129274 | CID_141058406 | |
| 0.034 | 0.211 | 0.167 | M18 aspartyl aminopeptidase inhibitor | 0.132 0.062 CID_141058406 0.127 0.065 CID_135290 0.167 0.044 CID_129274 | CID_129274 | |
| 0.015 | 0.207 | 0.046 | Estrogen-related receptor beta antagonist | 0.031 0.026 CID_141058406 0.039 0.012 CID_135290 0.046 0.007 CID_129274 | CID_129274 | |
| 0.104 | 0.297 | 0.202 | Transcription factor NF kappa B inhibitor | 0.192 0.177 CID_141058406 0.202 0.167 CID_129274 | CID_129274 | |
| 0.038 | 0.232 | 0.057 | Heme oxygenase stimulant | 0.057 0.055 CID_141058406 | CID_141058406 | |
| 0.08 | 0.303 | 0.12 | Papain-like protease (SARS coronavirus) inhibitor | 0.113 0.101 CID_135290 0.12 0.081 CID_129274 | CID_129274 | |
| 0.037 | 0.264 | 0.096 | Aminoacyl-tRNA synthetase inhibitor | 0.096 0.05 CID_141058406 | CID_141058406 | |
| 0.061 | 0.336 | 0.101 | Interleukin 2 antagonist | 0.101 0.088 CID_2555 | CID_2555 | |
| 0.037 | 0.313 | 0.165 | Lipid peroxidase inhibitor | 0.143 0.073 CID_141058406 0.15 0.068 CID_135290 0.165 0.058 CID_129274 | CID_129274 | |
| 0.046 | 0.366 | 0.136 | Interleukin 4 antagonist | 0.124 0.079 CID_141058406 0.123 0.081 CID_135290 0.136 0.064 CID_129274 | CID_129274 | |
| 0.024 | 0.364 | 0.101 | Tubulin antagonist | 0.101 0.1 CID_141058406 | CID_141058406 | |
| 0.099 | 0.451 | 0.172 | ErbB-1 antagonist | 0.172 0.13 CID_135290 | CID_135290 | |
| 0.045 | 0.402 | 0.093 | Interleukin 12 antagonist | 0.093 0.067 CID_135290 | CID_135290 | |
| 0.037 | 0.445 | 0.443 | Antimitotic | 0.443 0.018 CID_2555 | CID_2555 | |
| 0.008 | 0.422 | 0.055 | Alpha tubulin antagonist | 0.055 0.035 CID_141058406 | CID_141058406 | |
| 0.014 | 0.444 | 0.043 | DNA gyrase subunit A inhibitor | 0.043 0.028 CID_141058406 | CID_141058406 | |
| 0.004 | 0.499 | 0.032 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.032 0.027 CID_129274 | CID_129274 | |
| 0.031 | 0.528 | 0.232 | Antioxidant | 0.21 0.107 CID_141058406 0.201 0.113 CID_135290 0.232 0.094 CID_129274 | CID_129274 | |
| 0.002 | 0.545 | 0.032 | Estrogen receptor alpha agonist | 0.032 0.025 CID_129274 | CID_129274 | |
| 0.01 | 0.596 | 0.103 | Topoisomerase II inhibitor | 0.103 0.083 CID_141058406 | CID_141058406 | |
| 0.017 | 0.604 | 0.214 | Free radical scavenger | 0.199 0.099 CID_141058406 0.189 0.107 CID_135290 0.214 0.087 CID_129274 | CID_129274 | |
| 0.029 | 0.617 | 0.083 | T cell inhibitor | 0.083 0.056 CID_2555 | CID_2555 | |
| 0.003 | 0.625 | 0.127 | Squalene synthetase inhibitor | 0.127 0.005 CID_2555 | CID_2555 | |
| 0.009 | 0.654 | 0.131 | Estrogen receptor beta antagonist | 0.105 0.056 CID_141058406 0.129 0.024 CID_135290 0.131 0.023 CID_129274 | CID_129274 | |
| 0.003 | 0.672 | 0.045 | Estrogen agonist | 0.045 0.039 CID_129274 | CID_129274 | |
| 0.009 | 0.75 | 0.139 | Estrogen antagonist | 0.11 0.074 CID_141058406 0.136 0.032 CID_135290 0.139 0.029 CID_129274 | CID_129274 | |
| 0.033 | 0.804 | 0.2 | Sodium/bile acid cotransporter inhibitor | 0.2 0.188 CID_129274 | CID_129274 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |